- Home
- CSTM vs CPRX Comparison
CSTM vs CPRX Comparison
Compare CSTM & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSTM | CPRX |
|---|---|---|
| Founded | 2010 | 2002 |
| Country | France | United States |
| Employees | 12000 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2012 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CSTM | CPRX |
|---|---|---|
| Price | $25.34 | $24.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $29.00 | ★ $33.25 |
| AVG Volume (30 Days) | ★ 1.9M | 1.1M |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 107.94 |
| EPS | 1.13 | ★ 1.27 |
| Revenue | ★ $7,335,000,000.00 | $119,072,803.00 |
| Revenue This Year | N/A | $19.98 |
| Revenue Next Year | $3.46 | $6.96 |
| P/E Ratio | $22.85 | ★ $19.25 |
| Revenue Growth | N/A | ★ 16.39 |
| 52 Week Low | $7.33 | $19.05 |
| 52 Week High | $27.25 | $26.56 |
Technical Indicators
Market Signals| Indicator | CSTM | CPRX |
|---|---|---|
| Relative Strength Index (RSI) | 64.25 | 50.44 |
| Support Level | $22.32 | $24.01 |
| Resistance Level | $27.25 | $24.86 |
| Average True Range (ATR) | 1.23 | 0.78 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 63.79 | 37.61 |
Price Performance
Historical ComparisonAbout CSTM Constellium SE (France)
Constellium SE is engaged in the design and manufacture of rolled and extruded aluminium products, serving the packaging, aerospace, automotive, defence and other transportation and industry end-markets. The business is organized into three operating segments: the Packaging and Automotive Rolled Products segment which includes the production of rolled aluminium sheet products in European and North American facilities; the Aerospace and Transportation segment includes the production of rolled aluminium products and very limited volumes of extruded products in European and North American facilities; the Automotive Structures and Industry segment includes the production of extruded aluminium products and aluminium structural components.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).